ERBB2 and breast carcinoma: For example, iso-211At-SAGMB-anti-HER2-sdAb conjugates have been shown to significantly delay tumor growth and prolong survival in a mouse model of HER2-expressing breast cancer with no apparent toxicity to normal tissue15.